Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex.
Prévost GP, Lonchampt MO, Holbeck S, Attoub S, Zaharevitz D, Alley M, Wright J, Brezak MC, Coulomb H, Savola A, Huchet M, Chaumeron S, Nguyen QD, Forgez P, Bruyneel E, Bracke M, Ferrandis E, Roubert P, Demarquay D, Gespach C, Kasprzyk PG.
Prévost GP, et al. Among authors: huchet m.
Cancer Res. 2006 Sep 15;66(18):9227-34. doi: 10.1158/0008-5472.CAN-05-4205.
Cancer Res. 2006.
PMID: 16982767